Pfizer Announces New Strategic Partnerships with ICON and PAREXEL International Corporation
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Nycomed continues to outperform in emerging markets in first quarter 2011
- Details
- Category: Nycomed
![Nycomed Nycomed](/images/stories/logo/nycomed.gif)
GSK forms partnership with three leading NGOs
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
AstraZeneca signs agreement in Japan with Daiichi Sankyo to co-promote denosumab
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Lilly and Investor Group Form New Critical Care Company BioCritica
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](/images/stories/logo/lilly.gif)
Sanofi's Commitment to Research and Identify Treatments for Cancer Patients
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/stories/logo/sanofi.gif)
More Pharma News ...
- SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
- Takeda to Acquire Nycomed - Transaction will Transform Takeda's Global Business
- Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO
- Shire to establish new Regenerative Medicine business unit through cash acquisition of Advanced BioHealing, Inc.
- Pfizer To Present New Research From Fifteen Compounds
- Patrick Dempsey Teams up With Breakaway from Cancer(R)
- New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer